$31.97 -0.24 (%) Myriad Genetics Inc - NASDAQ

Jul. 22, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. RS Investment Sells Stake in Debt Collection Company

    GuruFocus | Feb. 17, 2016 | 14:14PM EST
  2. Chuck Royce Reduces Several Positions in 4th Quarter

    GuruFocus | Feb. 5, 2016 | 17:30PM EST
  3. Apple Rises On Upgrade, China; Lululemon Jumps On Brighter View

    IBD | Jan. 12, 2016 | 13:51PM EST
  4. 4 Stocks Moving On Breast-Cancer News

    IBD | Dec. 10, 2015 | 16:04PM EST
  5. Benzinga's Top Upgrades

    Benzinga | Dec. 8, 2015 | 09:01AM EST
  6. Myriad RBM DiscoveryMAP Technology Identifies Novel Biomarkers That May Predict Increased Risk of Cardiovascular Events in Patients With Diabetes

    Benzinga | Nov. 16, 2015 | 07:12AM EST
  7. Crescendo Bioscience Vectra DA Data to be Presented at American College of Rheumatology 2015 Annual Meeting

    Benzinga | Nov. 7, 2015 | 20:05PM EST
  8. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest EPS

    Benzinga | Oct. 19, 2015 | 04:18AM EST
  9. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Oct. 7, 2015 | 08:05AM EST
  10. Myriad Genetics, Tufts Health Plan Sign 3-Year Contract to Cover Prolaris for Members With Localized Prostate Cancer

    Benzinga | Oct. 7, 2015 | 07:07AM EST
  11. Myriad Genetics and Tufts Health Plan Sign Agreement to Cover Prolaris(R) for Members With Localized Prostate Cancer

    Benzinga | Oct. 7, 2015 | 07:05AM EST
  12. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD | Oct. 5, 2015 | 08:02AM EST
  13. Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting

    Benzinga | Sep. 24, 2015 | 07:05AM EST
  14. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest Revenue

    Benzinga | Sep. 17, 2015 | 04:23AM EST
  15. Myriad Announces Favorable Medicare Final Coverage Decision for the ProlarisR) Test

    Benzinga | Aug. 13, 2015 | 07:06AM EST
  16. Tuesday's After-Hours Movers Led By Fossil, Cree And Myriad

    Benzinga | Aug. 11, 2015 | 16:47PM EST
  17. Must Watch Stocks for August 11, 2015

    Benzinga | Aug. 11, 2015 | 05:03AM EST
  18. Fossil Group, Myriad Genetics Among The Earnings Reports To Keep An Eye On Tuesday

    Benzinga | Aug. 10, 2015 | 16:27PM EST
  19. Heavy News Day For Several Biotech Stocks

    Benzinga | Feb. 25, 2015 | 15:34PM EST
  20. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga | Feb. 17, 2015 | 12:17PM EST
  21. JMP Securities Upgrades Myriad Genetics, Says 'Revised Guidance Lowers The Bar'

    Benzinga | Feb. 4, 2015 | 12:03PM EST
  22. Morning Market Losers

    Benzinga | Feb. 4, 2015 | 09:54AM EST
  23. Wednesday Morning Movers: Gilead Sciences, Myriad Genetics Tumble Following Earnings

    Benzinga | Feb. 4, 2015 | 09:39AM EST
  24. Benzinga's Top Upgrades

    Benzinga | Feb. 4, 2015 | 08:40AM EST
  25. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 4, 2015 | 08:16AM EST
  26. JMP Securities Upgrades Myriad Genetics To Outperform

    Benzinga | Feb. 4, 2015 | 07:43AM EST
  27. Tuesday's After-Hours Movers: Gilead, Wynn Resorts And Chipotle Fall Following Earnings

    Benzinga | Feb. 3, 2015 | 17:53PM EST
  28. Earnings Scheduled For February 3, 2015

    Benzinga | Feb. 3, 2015 | 04:59AM EST
  29. Big Short Interest On These 5 Biotech Stocks

    Benzinga | Jan. 12, 2015 | 15:36PM EST
  30. Barclays Initiates Coverage On Life Science Tools & Diagnostics, Names Thermo Fisher As 'Top Pick'

    Benzinga | Jan. 7, 2015 | 16:41PM EST
  31. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  32. AstraZeneca

    IBD | Dec. 19, 2014 | 18:25PM EST
  33. A Closer Look At 5 Heavily Shorted Stocks

    Benzinga | Dec. 12, 2014 | 11:02AM EST
  34. Study Shows Prolaris Could Save Healthcare System $6B Over 10 Yrs.

    Benzinga | Dec. 2, 2014 | 07:03AM EST
  35. Myriad Genetics' Crescendo Bioscience Offers New Clinical Data on Vectra(R) DA at ACR

    Benzinga | Nov. 19, 2014 | 07:07AM EST
  36. Top Performing Industries For November 12, 2014

    Benzinga | Nov. 12, 2014 | 10:59AM EST
  37. UPDATE: Morgan Stanley Initiates Coverage On Myriad Genetics As Survey Points To Greater Share Loss

    Benzinga | Nov. 10, 2014 | 09:15AM EST
  38. Benzinga's Top Initiations

    Benzinga | Nov. 10, 2014 | 09:04AM EST
  39. Crescendo Bioscience To Feature New Data On Vectra DA At 2014 ACR Meeting

    Benzinga | Nov. 10, 2014 | 07:43AM EST
  40. MYRIAD GENETICS

    IBD | Nov. 4, 2014 | 18:52PM EST
  41. Earnings Scheduled For November 4, 2014

    Benzinga | Nov. 4, 2014 | 05:31AM EST
  42. Gene tester obtains coverage

    IBD | Oct. 17, 2014 | 18:43PM EST
  43. Myriad Gets Reimbursement OK On Prostate Cancer Test

    IBD | Oct. 17, 2014 | 14:05PM EST
  44. Morning Market Losers

    Benzinga | Oct. 17, 2014 | 10:03AM EST
  45. Myriad Appoints R. Bryan Riggsbee As CFO

    Benzinga | Oct. 8, 2014 | 16:07PM EST
  46. Myriad Reports Tumor Bracanalysis CDX Has Identified 44% More Candidates for PARP Therapy

    Benzinga | Sep. 29, 2014 | 07:40AM EST
  47. Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed Treatment In 35 % Of Cases

    Benzinga | Sep. 9, 2014 | 07:08AM EST
  48. Myriad Publishes myRisk Hereditary Cancer Study In Cancer

    Benzinga | Sep. 3, 2014 | 16:06PM EST
  49. FuelCell Upgrade; Amazon Announces New Product

    Benzinga | Aug. 13, 2014 | 15:28PM EST
  50. SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

    Benzinga | Aug. 13, 2014 | 12:49PM EST
Trading Center